Stay informed with the latest litigation news. Explore now

Cl Biosciences patent opposition analysis

Latest patents of Cl Biosciences New

Explore the latest patents granted to Cl Biosciences, showcasing their recent innovations and technological advancements.

Last updated on: Aug 31, 2025
Patent NumberGrant DateTitleLegal Status

Get instant update for new patents of Cl Biosciences

Feb 17, 2021Gastrin Antagonists (Eg Yf476, Netazepide) For Treatment And Prevention Of OsteoporosisGranted And Under Opposition

Explore Cl Biosciences's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 4, 2025
Patent NumberGrant DateTitleTotal Oppositions
Feb 17, 2021Gastrin Antagonists (Eg Yf476, Netazepide) For Treatment And Prevention Of Osteoporosis1

Top competitors of Cl Biosciences

Top competitors of Cl Biosciences based on patent oppositions.